Clinical trial NCT05094141: Comparing Virtual Reality (VR) to Non-VR for Decreasing Preoperative/Procedural Anxiety
Official title: Randomized Pilot Crossover Study Comparing Virtual Reality (VR) and Non-VR Distraction for Decreasing Preoperative/Procedural Anxiety As a Function of the Modified Yale Preoperative Anxiety Scale (mYPAS)
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Preoperative Anxiety
Keywords: virtual reality
preoperative anxiety
modified Yale Preoperative Anxiety Scale
Lead sponsor: University of Texas Southwestern Medical Center
Sponsor class: OTHER
First posted: 2021-10-26
Enrollment: 89
Sex: ALL
Minimum age (years): 5
Maximum age (years): 12
Standard ages: CHILD
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Intervention model description: Cross over study will be performed. Subjects will be randomized (1 to 1 randomization) at their initial encounter to either VR or Non-VR. During their second visit patients will be given the alternative mode of care (i.e. patients who initially received VR distraction will be given Non-VR distraction, and patients who initially received Non- VR distraction will receive VR distraction)
Primary purpose: TREATMENT

Brief summary: The primary objective of the study is to utilize the modified Yale Preoperative Anxiety scale (mYPAS), a validated preoperative/procedural anxiety score, to measure preoperative anxiety via distraction in pediatric oncology patients undergoing port access.

The hypothesis is that using Virtual Reality (VR) will objectively decrease anxiety scores measured by mYPAS by five percent (primary outcome).

The secondary outcome will be the parents or the legally authorized representative (LAR) subjective reports of anxiety with the use of VR.

The Kind VR device is used in house at Children's Health in the Dallas and Plano campuses. The VR device used in this study qualifies as exempt from FDA IDE regulations. It is a non-significant risk, non-invasive, interactive video device the user wears like goggles. The study carries minimal risks to the subjects and is designed to minimize patient discomfort from placement or motion sickness. Furthermore, the device has disposable covers for protection against infection and can be sanitized between uses, once the disposable covers are removed. Children's Health System of Texas (CHST) and this research group are not partnering entities with the Kind VR, and the Kind VR device is not being studied. The effect of virtual reality (VR) on preprocedural anxiety as measured by questionnaires and the observations of the modified Yale Preoperative Anxiety Scale (mYPAS) is being studied

Most patients coming to the Clinic of Cancer and Blood Disorders (CCBD) are under chronic care for their ongoing disease and are likely to be coming to the CCBD at least twice in a 6-month period. The CCBD schedule will be reviewed by the researchers for patients age 5-12, requiring port access at least twice during the next six-month period. Patient families whose child meets the basic screening criteria, and have no exclusion criteria, will be approached privately as possible participants in the study. Up to 100 subjects will be enrolled over a 2-year period. Once the subject/parent or LAR agrees to participate, study staff will randomize the subjects into which standard of care distraction method for anxiety management they will receive first in this study.


Eligibility criteria: Inclusion Criteria:

* Any patient of the Children's Medical Center CCBD
* 5-12 years of age
* Patient requiring their port accessed twice or more within a 6 months period
* Ability to understand and the willingness to sign a written informed consent.

Exclusion Criteria

* Subjects younger than 5 and older than 12
* Patients requiring recovery in PICU or sites other than PACU
* If parents or subject is not willing to participate
* Subjects with severe developmental delays and subjects with developmental challenges preventing them from keeping the VR device on are also excluded
* Patients who will not be in CCBD for port access at least twice in 6 months

Primary outcomes:
measure: Preoperative anxiety score in pediatric oncology patients
timeFrame: 2 years
measure: Number of parents or legally authorized representative (LAR) who subjectively report decreased anxiety with the use of VR
timeFrame: 2 years
Secondary outcomes:
Other outcomes:
Locations:
city: Dallas
country: United States
facility: Kiley Poppino
state: Texas
Study officials:
affiliation: UT Southwestern
name: Sarah Rebstock, MD
role: PRINCIPAL_INVESTIGATOR
affiliation: UT Southwestern
name: Neethu Chandran
role: PRINCIPAL_INVESTIGATOR
References: